{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:58:19Z","timestamp":1772557099158,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ejso.2025.110000","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T17:20:42Z","timestamp":1743873642000},"page":"110000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Survival outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in selected patients with stage IV gastric adenocarcinoma \u2013 A Canadian case series"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8869-2851","authenticated-orcid":false,"given":"Florence","family":"B\u00e9nard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Marcil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lloyd","family":"Mack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1768-263X","authenticated-orcid":false,"given":"Melina","family":"Deban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bildersheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Bouchard-Fortier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmin","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kieran","family":"Purich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8756-6626","authenticated-orcid":false,"given":"Erika","family":"Haase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Schiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4576-5774","authenticated-orcid":false,"given":"Mikael","family":"Soucisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Sid\u00e9ris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Leblanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Dub\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy","family":"Boulanger-Gobeil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai-Kim","family":"Gervais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2025.110000_bib1","unstructured":"Gastric Cancer. Available online: https:\/\/www.cancer.ca\/en\/cancer-information\/cancer-type\/stomach\/stomach-cancer\/?region=bc (accessed on June 2020)."},{"key":"10.1016\/j.ejso.2025.110000_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15092639","article-title":"Updated epidemiology of gastric cancer in Asia: decreased incidence but still a big challenge","volume":"15","author":"Shin","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejso.2025.110000_bib3","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ijc.28373","article-title":"Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors","volume":"134","author":"Thomassen","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejso.2025.110000_bib4","unstructured":"NCCN. Gastric Cancer. Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/gastric.pdf (accessed on June 9, 2024)."},{"key":"10.1016\/j.ejso.2025.110000_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa073149","article-title":"Capecitabine and oxaliplatin for advanced esophagogastric cancer","volume":"358","author":"Cunningham","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2025.110000_bib6","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2025.110000_bib7","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S1470-2045(18)30739-3","article-title":"Trifluridine\/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"19","author":"Shitara","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2025.110000_bib8","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S1470-2045(14)70420-6","article-title":"Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial","volume":"15","author":"Wilke","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2025.110000_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2025.110000_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/bjs.7812","article-title":"Prognostic significance of peritoneal washing cytology in patients with gastric cancer","volume":"99","author":"Lee","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2025.110000_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10120-014-0388-5","article-title":"A systematic review and meta-analysis of gastric cancer treatment in patients with positive peritoneal cytology","volume":"18","author":"Cabalag","year":"2015","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejso.2025.110000_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11864-020-00774-4","article-title":"Targeted therapies in advanced gastric cancer","volume":"21","author":"Patel","year":"2020","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.ejso.2025.110000_bib13","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2025.110000_bib14","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2025.110000_bib15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2025.110000_bib16","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.3748\/wjg.v22.i3.1114","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer","volume":"22","author":"Seshadri","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejso.2025.110000_bib17","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial","volume":"18","author":"Yang","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110000_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jso.23633","article-title":"Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial","volume":"110","author":"Rudloff","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110000_bib19","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12885-019-5640-2","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)","volume":"19","author":"Koemans","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2025.110000_bib20","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","article-title":"Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy","volume":"17","author":"Glehen","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110000_bib21","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1200\/JCO.18.01688","article-title":"Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis","volume":"37","author":"Bonnot","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2025.110000_bib22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejso.2020.10.006","article-title":"Long term survival in patients with peritoneal metastasised gastric cancer treated with cytoreductive surgery and HIPEC: a multi-institutional cohort from PSOGI","volume":"47","author":"Brandl","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110000_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejso.2013.10.019","article-title":"Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials","volume":"40","author":"Coccolini","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110000_bib24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3109\/02656736.2013.768359","article-title":"Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: a systematic review and meta-analysis of randomised controlled trials","volume":"29","author":"Mi","year":"2013","journal-title":"Int J Hyperther"},{"key":"10.1016\/j.ejso.2025.110000_bib25","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1177\/0300060519882545","article-title":"Effect of hyperthermic intraperitoneal chemotherapy for gastric cancer patients: a meta-analysis of the randomized controlled trials","volume":"47","author":"Liu","year":"2019","journal-title":"J Int Med Res"},{"key":"10.1016\/j.ejso.2025.110000_bib26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1245\/s10434-020-08739-5","article-title":"A phase II trial of cytoreduction, gastrectomy, and hyperthermic intraperitoneal perfusion with chemotherapy for patients with gastric cancer and carcinomatosis or positive cytology","volume":"28","author":"Badgwell","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110000_bib27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1200\/JCO.22.02867","article-title":"Effect of hyperthermic intraperitoneal chemotherapy on cytoreductive surgery in gastric cancer with synchronous peritoneal metastases: the phase III GASTRIPEC-I trial","volume":"42","author":"Rau","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2025.110000_bib28","doi-asserted-by":"crossref","first-page":"8549","DOI":"10.1245\/s10434-024-16142-7","article-title":"Survival outcomes of cytoreductive surgery with HIPEC in gastric adenocarcinoma: a national cancer database study","volume":"31","author":"Khomiak","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110000_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15245742","article-title":"Claudin18.2 in advanced gastric cancer","volume":"15","author":"Inamoto","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejso.2025.110000_bib30","doi-asserted-by":"crossref","unstructured":"Turaga, K.K. Consensus guideline for the management of gastric cancer with synchronous peritoneal metastases. medRxiv 2024, 2024.2004.2010.24305456, doi:10.1101\/2024.04.10.24305456.","DOI":"10.1101\/2024.04.10.24305456"},{"key":"10.1016\/j.ejso.2025.110000_bib31","doi-asserted-by":"crossref","first-page":"8115","DOI":"10.1245\/s10434-023-13932-3","article-title":"The 2022 PSOGI international Consensus on HIPEC regimens for peritoneal malignancies: epithelial ovarian cancer","volume":"30","author":"Bhatt","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110000_bib32","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1245\/s10434-023-14368-5","article-title":"Peritoneal Surface oncology group international Consensus on HIPEC regimens for peritoneal malignancies: colorectal cancer","volume":"31","author":"H\u00fcbner","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110000_bib33","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/jso.27885","article-title":"Review of 2022 PSOGI\/RENAPE Consensus on HIPEC","volume":"130","author":"Kusamura","year":"2024","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110000_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103841","article-title":"Characteristics of gastric cancer around the world","volume":"181","author":"L\u00f3pez","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejso.2025.110000_bib35","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.18457","article-title":"Global incidence and mortality of gastric cancer, 1980-2018","volume":"4","author":"Wong","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejso.2025.110000_bib37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1245\/s10434-023-14415-1","article-title":"Gastrectomy + cytoreductive surgery + HIPEC for gastric cancer with peritoneal dissemination (PERISCOPE II)","volume":"31","author":"Sarvestani","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110000_bib38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1471-2407-14-183","article-title":"GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study","volume":"14","author":"Glehen","year":"2014","journal-title":"BMC Cancer"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325004287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325004287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T05:39:41Z","timestamp":1755495581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325004287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0748798325004287"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110000","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in selected patients with stage IV gastric adenocarcinoma \u2013 A Canadian case series","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110000","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110000"}}